HEMOTUNE
Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments.
HEMOTUNE
Industry:
Biotechnology Health Care Life Science Medical Device Therapeutics
Founded:
2016-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.hemotune.ch
Total Employee:
11+
Status:
Active
Contact:
+41 44 633 41 51
Email Addresses:
[email protected]
Total Funding:
18.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
PatchMeBaby
PatchMeBaby is an implantable medical device that closes and secures the hole created by the endoscopes.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Severn Sales
Severn Sales is a cost-effective medical device provider company that has an expert provision of laboratory equipment and supplies.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
VP Venture Partners
VP Venture Partners investment in Series B - Hemotune
OCCIDENT
OCCIDENT investment in Series B - Hemotune
Hemex
Hemex investment in Series B - Hemotune
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series B - Hemotune
OCCIDENT
OCCIDENT investment in Series A - Hemotune
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series A - Hemotune
EIT Health
EIT Health investment in Grant - Hemotune
InnoSuisse
InnoSuisse investment in Grant - Hemotune
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Hemotune
Eurostars
Eurostars investment in Grant - Hemotune
Official Site Inspections
http://www.hemotune.ch
- Host name: mxvp931.mail.hostserv.eu
- IP address: 82.220.38.62
- Location: Schindellegi Switzerland
- Latitude: 47.1746
- Longitude: 8.7134
- Timezone: Europe/Zurich
- Postal: 8834
More informations about "Hemotune"
About us - hemotune
Hemotune is a spin-off company originating out of the Functional Materials Lab at ETH Zurich. hemotune was founded in 2017 and is moving forward to redefine blood purification …See details»
hemotune - Wyss Zurich
Sep 28, 2023 hemotune AG is developing a proprietary magnetic nanoparticle technology, the HemoSystem, to allow more selective, efficient, and milder removal of disease-related …See details»
Hemotune: Revenue, Worth, Valuation & Competitors 2025
About Hemotune. Hemotune is a Medical Equip related company founded in 2017 and based in Zurich with 24 employees an estimated revenue of $8M, and. It has 10 competitors including …See details»
Hemotune 2025 Company Profile: Valuation, Funding …
Hemotune General Information Description. Developer of a therapeutic blood purification platform designed to develop blood purification technology. The company's platform offers treatments based on magnetic beads that allow …See details»
Hemotune - Crunchbase Company Profile & Funding
Organization. Hemotune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
hemotune AG - Venture Kick
25.03.2024 CHF 14 million to fund hemotune’s clinical trials (startupticker.ch) 22.01.2024 How Zühlke and Venturelab create a win-win ecosystem for startups (venturelab.swiss) 28.04.2023 Swiss Accelerator: Innosuisse supports 53 …See details»
hemotune | magnetic blood purification | Schlieren
Hemotune has designed a multi-target precision medicine blood purification treatment to restore immune balance in septic shock and improve patient outcomes. Learn more. Team. An interdisciplinary team of scientists, …See details»
hemotune raises CHF 14 million Series B2 funding for ... - OCCIDENT
Mar 25, 2024 About hemotune hemotune is a pioneering biotech company based in Schlieren, Switzerland. Leveraging nanotechnology, hemotune implements precision medicine …See details»
Hemotune raises CHF 7.25 million to develop blood purification …
Apr 26, 2022 Hemotune AG, a spin-off from ETH Zurich founded in 2017 and being accelerated by Wyss Zurich, today announced the closing of a CHF 7.25 million Series B1 for the …See details»
hemotune AG - startup.ch
Hemotune AG: hemotune AG is developping a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology. It allows specific and direct removal of disease-causing …See details»
CHF 5.1 million for blood purification startup hemotune
Aug 14, 2020 Despite the corona crisis, hemotune managed to build a very strong consortium led by OCCIDENT with participation of the Korean medical device company Greencross …See details»
Treatment - hemotune
At hemotune, an interdisciplinary team of scientists, engineers and clinicians combines cutting-edge clinical and scientific results to finding an effective treatment for septic shock patients. …See details»
Hemotune secures CHF 14 Million in Series B2 Funding to advance ...
Mar 26, 2024 Hemotune, a leading Swiss biotech firm renowned for its innovative blood purification solutions, has reached a significant achievement with the closure of a CHF 14 …See details»
NEWS & UPDATES - hemotune
News & Updates about hemotune and research around sepsis. top of page. Technology. Treatment. Quality. About us. News & Updates. Careers. Contact. More. NEWS & UPDATES. …See details»
Hemotune Secures CHF 14 Million for Clinical Trials
Mar 26, 2024 Photo courtesy of Hemotune. Hemotune AG, a Swiss biotech compmany, has concluded its Series B2 funding round, raising CHF 14 million, they claim in a press …See details»
hemotune raises CHF 14 million Series B2 funding for clinical trials ...
Feb 5, 2024 Initially focusing on treating sepsis-related immune suppression, hemotune also plans to explore other potential uses for the platform in the future. Given the serious impact of …See details»
hemotune AG - top100startup.ch
24.03.2023 AstraZeneca enters close collaboration with hemotune (startupticker.ch) 24.03.2023 hemotune initiates joint feasibility project on the HemoSystem with AstraZeneca (TOP 100) …See details»
hemotune raises CHF 14 million Series B2 funding for clinical trials ...
Mar 25, 2024 Schlieren, Switzerland, March 25th, 2024 – hemotune AG, a pioneering Swiss biotech company, today announced the successful closing of a CHF 14 million Series B2 …See details»
Technology - hemotune
The innovative principle behind hemotune's technology, based on magnetic nanoparticles removing harmful substances from the patient's bloodstream. top of page. Technology. …See details»
quality - hemotune
We achieve it through teamwork over all hierarchies, expecting from each hemotune employee to actively contribute to our quality goals. EN ISO 13485:2016. The EN ISO 13485 certification …See details»